Synthesis and Evaluation of Two 18F-Labeled 6-Iodo-2-(4′ -N,N-dimethylamino)phenylimidazo[1,2-a]pyridine Derivatives as Prospective Radioligands for β-Amyloid in Alzheimer's Disease

Lisheng Cai, Frederick T. Chin, Victor W. Pike, Hiroshi Toyama, Jeih San Liow, Sami S. Zoghbi, Kendra Modell, Emmanuelle Briard, H. Umesha Shetty, Kathryn Sinclair, Sean Donohue, Dnyanesh Tipre, Mei Ping Kung, Claudio Dagostin, David A. Widdowson, Michael Green, Weiyi Gao, Mary M. Herman, Masanori Ichise, Robert B. Innis

研究成果: Article

78 引用 (Scopus)

抜粋

This study evaluated 18F-labeled IMPY [6-iodo-2-(4′ -N,N-dimethylamino)phenylimidazo[1,2-a]pyridine] derivatives as agents for imaging β-amyloid plaque with positron emission tomography (PET). The precursor for radiolabeling and reference compounds was synthesized in up to five steps from commercially accessible starting materials. One of the two N-methyl groups of IMPY was substituted with either a 3-fluoropropyl (FPM-IMPY) or a 2-fluoroethyl (FEM-IMPY) group. FPM-IMPY and FEM-IMPY were found to have moderate affinity for Aβ-aggregates with Ki = 27 ± 8 and 40 ± 5 nM, respectively. A "one-pot" method for 18F-2-fluoroethylation and 18F-3-fluoropropylation of the precursor was developed. The overall decay-corrected radiochemical yields were 26-51%. In PET experiments with normal mouse, high uptake of activity was obtained in the brain after iv injection of each probe: 6.4% ID/g for [ 18F]FEM-IMPY at 1.2 min, and 5.7% ID/g for [18F]FPM-IMPY at 0.8 min. These values were similar to those of [123I/ 125I]IMPY (7.2% ID/g at 2 min). Polar and nonpolar radioactive metabolites were observed in both plasma and brain homogenates after injection of [18F]FEM or [18F]FPM-IMPY. In contrast to the single-exponential washout of [123I/125I]IMPY, the washouts of brain activity for the two fluorinated analogues were biphasic, with an initial rapid phase over 20 min and a subsequent much slower phase. Residual brain activity at 2 h, which may represent polar metabolites trapped in the brain, was 4.5% ID/g for [18F]FEM-IMPY and 2.1% ID/g for [18F]FPM-IMPY. Substantial skull uptake of [18F]fluoride was also clearly observed. With a view to slow the metabolism of [ 18F]FEM-IMPY, an analogue was prepared with deuteriums substituted for the four ethyl hydrogens. However, D4-[18F]FEM-IMPY showed the same brain uptake and clearance as the protio analogue. Metabolism of the [18F]FEM-IMPY was appreciably slower in rhesus monkey than in mouse. Autoradiography of postmortem brain sections of human Alzheimer's disease patients with [18F]FEM-IMPY showed high displaceable uptake in gray matter and low nonspecific binding in the white matter. This study demonstrates that the IMPY derivatives have favorable in vivo brain pharmacokinetics and a moderate affinity for imaging β-amyloid plaques; however, further improvements are needed to reduce radioactive metabolites, increase binding affinity, and reduce lipophilicity.

元の言語English
ページ(範囲)2208-2218
ページ数11
ジャーナルJournal of Medicinal Chemistry
47
発行部数9
DOI
出版物ステータスPublished - 22-04-2004
外部発表Yes

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Drug Discovery

フィンガープリント Synthesis and Evaluation of Two <sup>18</sup>F-Labeled 6-Iodo-2-(4′ -N,N-dimethylamino)phenylimidazo[1,2-a]pyridine Derivatives as Prospective Radioligands for β-Amyloid in Alzheimer's Disease' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用

    Cai, L., Chin, F. T., Pike, V. W., Toyama, H., Liow, J. S., Zoghbi, S. S., Modell, K., Briard, E., Shetty, H. U., Sinclair, K., Donohue, S., Tipre, D., Kung, M. P., Dagostin, C., Widdowson, D. A., Green, M., Gao, W., Herman, M. M., Ichise, M., & Innis, R. B. (2004). Synthesis and Evaluation of Two 18F-Labeled 6-Iodo-2-(4′ -N,N-dimethylamino)phenylimidazo[1,2-a]pyridine Derivatives as Prospective Radioligands for β-Amyloid in Alzheimer's Disease. Journal of Medicinal Chemistry, 47(9), 2208-2218. https://doi.org/10.1021/jm030477w